2016-03-15 17:31:27 CET

2016-03-15 17:31:27 CET


REGULATED INFORMATION

Finnish English
Revenio Group Oyj - Decisions of general meeting

Revenio Group Corporation: Decisions by the Annual General Meeting on March 15, 2016


Revenio Group Corporation, Stock Exchange Release, March 15, 2016 at 18.30

Decisions by the Annual General Meeting of Revenio Group Corporation on March
15, 2016

1. Financial statements, Board and Auditors

The AGM confirmed the company's financial statements for the financial year 1
January - 31 December 2015, and discharged the members of the Board of Directors
and the Managing Director from liability.

The AGM decided that five members be elected to the Board of Directors and re-
elected Ari Kohonen, Pekka Rönkä, Kyösti Kakkonen and Pekka Tammela as board
members and elected Ann-Christine Sundell as a new member. In its meeting held
after the AGM, the Board of Directors re-elected Pekka Tammela as chairman.

The AGM decided that the Chairman of the Board be entitled to an annual
emolument of EUR 48,000 and the other Board members to an annual emolument of
EUR 24,000.

A total of 40 per cent of Board members' emoluments will be settled in the form
of company shares, while 60 per cent will comprise a monetary payment.

The AGM re-elected PricewaterhouseCoopers Oy, Authorized Public Accountants, as
the company's auditors with Samuli Perälä, Authorized Public Accountant, acting
as the principal auditor. The AGM decided to compensate the auditors, upon the
presentation of a reasonable invoice.

2. Annual profit distribution, dividend distribution and capital repayment

The AGM decided to accept the Board's proposal on profit distribution, according
to which the profit for the financial period, EUR 5,759,744.54, will be added to
retained earnings, and a dividend of EUR 0.70 per share will be paid. Dividends
will be paid to shareholders who have been registered in the company's
shareholder register, maintained by Euroclear Finland Ltd, by the dividend
record date on March 17, 2016. The dividend payment date is March 24, 2016.

3. Authorizing the Board of Directors to decide to repurchase the Company's own
shares

The AGM authorized the Board to make the decision to buy back a maximum of
795,392 of the company's own sharesin one or several tranches using the
Company's non-restricted equity capital. The company may buy back shares in
order to develop its capital structure, finance and implement any corporate
acquisitions or other transactions, implement share-based incentive plans, or
otherwise transfer or cancel them.

The company may buy back shares in public trading on marketplaces whose rules
and regulations allow the Company to trade in its own shares. In such a case,
the Company buys back shares through a directed purchase, that is, in a
proportion other than its shareholders' holdings in Company shares, with the
consideration for the shares based on their publicly quoted market price, in
such a manner that the minimum price of the purchased shares equals the lowest
market price quoted in public trading during the authorization period, and,
similarly, their highest price equals the highest market price quoted in public
trading during that period.

This authorization will be valid until April 30, 2017. This authorization shall
supersede the buyback authorization granted at the AGM of March 19, 2015.

4. Authorizing the Board of Directors to decide on a share issue and on the
granting of stock options and other special rights conferring entitlement to
shares

The AGM authorized the Board of Directors to decide on the issuance, following
the approval of the reverse share split, of a maximum of 795,392 shares or to
grant special rights (including stock options) entitling holders to shares as
referred to in Chapter 10 Section 1 of the Companies Act, in one or several
tranches.

This authorization was granted for the purpose of financing and implementing any
prospective corporate acquisitions or other transactions, implementing the
company's share-based incentive plans, or for other purposes determined by the
Board.

The authorization grants the Board's right to decide on all terms and conditions
governing said share issue and the granting of special rights, including the
subscribers or grantees of said special rights and the payable consideration.
Moreover, the authorization also includes the right to waive shareholders' pre-
emptive subscription rights and covers the issue of new shares and the transfer
of any shares that may be held by the company.

This authorization will be valid until April 30, 2017. This authorization shall
supersede the authorization to decide on a share issue and on the granting of
special rights giving entitlement to shares granted in the AGM of March
19, 2015.


Revenio Group Corporation
Board of Directors


For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose
worldwide success is based on a strongly patented intraocular pressure
measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio
Research Oy and Oscare Medical Oy, in which Revenio holds a 53% interest. The
common denominators of Revenio's business operations include screening, follow-
up and the global need to make cost savings through preventive health care.
Revenio seeks vigorous growth in health technology. Revenio aims at developing
even more efficient and easily adopted methods for the early-stage detection of
diseases with significance for public health. The focus of Revenio's screening
technology is on the early detection of glaucoma, osteoporosis, skin cancer and
asthma, and the monitoring of these during the treatment process.

In 2015, the Revenio Group's net sales totaled MEUR 20.3, with its operating
margin for continuing operations standing at 28.4%. Revenio Group Corporation is
listed on Nasdaq Helsinki.




[HUG#1994284]